Related Experiment Video

Updated: Aug 20, 2026

A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection
09:18

A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection

Published on: March 8, 2017

Medical management of childhood hearing loss

Margaret A Kenna1

  • 1Harvard Medical School, Department of Otolaryngology and Communication Disorders, Children's Hospital Boston, MA, USA.

Pediatric Annals
|December 24, 2004
PubMed

Insights

Early identification and intervention are key to managing childhood hearing loss. Advances in diagnostics and treatments improve outcomes for children with hearing impairments, maximizing their development.

Area of Science:

  • Pediatrics
  • Otolaryngology
  • Genetics

Background:

  • Childhood hearing loss is a prevalent condition affecting development.
  • Early diagnosis of infectious diseases, genetic factors, and anatomical abnormalities is crucial.

Purpose of the Study:

  • To review current advancements in identifying and treating hearing loss in children.
  • To emphasize the importance of early intervention for optimal communication and development.

Main Methods:

  • Review of recent diagnostic technologies including genetic testing and imaging.
  • Analysis of medical, surgical, and rehabilitative treatment options.
  • Discussion of emerging therapies like antiviral agents and genetic therapy.

Main Results:

  • Conductive hearing loss (CHL) often has favorable outcomes with medical or surgical management.
  • Sensorineural hearing loss (SNHL) can benefit from new treatments and assistive devices.
  • Technological advancements offer significant rehabilitation potential for severe to profound hearing losses.

Conclusions:

  • Early identification and prevention strategies are paramount for combating childhood hearing loss.
  • Timely treatment and rehabilitation minimize the impact of hearing loss on a child's life.
  • A multi-faceted approach combining diagnostics, medical/surgical interventions, and assistive technologies is essential.

More Related Videos

Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages06:04

Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages

Published on: March 24, 2023

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...